Skip to main navigation

Skip to content

Search for:

About
Science
Pipeline
Products
- XIPERE™
Investors

Investor Menu

IR Overview
News
Events and Presentations
Governance
SEC Filings
Financial Info
Resources

News

Year

Dec 21 2021

Clearside Biomedical Announces Positive Safety Results from OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD

Dec 13 2021

Clearside Biomedical Added to the Nasdaq Biotechnology Index

Nov 16 2021

Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy of Ophthalmology 2021 and American Uveitis Society Meetings

Nov 11 2021

Clearside Biomedical to Participate in Upcoming Investor Events in November and December 2021

Nov 10 2021

Clearside Biomedical Announces Third Quarter 2021 Financial Results and Provides Corporate Update

Oct 28 2021

Clearside Biomedical to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Wednesday, November 10, 2021

Oct 13 2021

Clearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Specialists (ASRS) Annual Meeting

Oct 4 2021

Clearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scientific Meeting

Sep 21 2021

Clearside Biomedical Announces Completion of Dosing in Cohort 2 of Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMD Patients

Sep 9 2021

Clearside Biomedical Expands XIPERE™ License Agreement with Arctic Vision to Include Australia, New Zealand, India and ASEAN Countries

Current page 1
Page 2
Page 3
Next page
Last page

Email Alerts
Print Page
RSS Feeds
IR Contact

Request Email Alerts

(678) 270-3631
info@clearsidebio.com
CONTACT US

ABOUT US
MANAGEMENT
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
PRIVACY POLICY

SCIENCE
SUPRACHOROIDAL SPACE
SCS MICROINJECTOR®
PUBLICATIONS & PRESENTATIONS
Intellectual Property

PRODUCTS
XIPERE™

PIPELINE
CLS-AX
INTEGRIN INHIBITOR
GENE THERAPY
COLLABORATIONS

INVESTORS
IR OVERVIEW
NEWS
EVENTS & PRESENTATIONS
GOVERNANCE
SEC FILINGS
FINANCIAL INFO
RESOURCES

Copyright 2022 © Clearside Biomedical | Website Design and Development by Emma Tang Designs